Ancient viruses in the fight against HIV

Drug Discovery Today

Volumn 8, Issue 7, 2003, Pages 287-291

  Sanders, David Avram ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS FUSION PROTEIN;

HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FUSION; MURINE LEUKEMIA VIRUS; NONHUMAN; REVIEW; VIRUS ENVELOPE;

EID: 0037377182     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02651-5     Document Type: Note

References (48)

1. Dutch R.E., et al. Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci. Rep. 20:2000;597-612.
2. Chan D.C., Kim P.S. HIV entry and its inhibition. Cell. 93:1998;681-684.
3. Kilby J.M., et al. The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res. Hum. Retroviruses. 18:2002;685-693.
4. Wei X., et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:2002;1896-1905.
5. Fass D., et al. Retrovirus envelope domain at 1.7 angstrom resolution. Nat. Struct. Biol. 3:1996;465-469.
6. Fass D., et al. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science. 277:1997;1662-1666.
7. Pinter A., et al. The nature of the association between the murine leukemia virus envelope proteins. Virology. 91:1978;345-351.
8. Pinter A., et al. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:1997;8073-8077.
9. Opstelten D.J., et al. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J. Virol. 72:1998;6537-6545.
10. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Hilderson H., Fuller S. Fusion of Biological Membranes and Related Problems. 2000;483-514 Kluwer Academic/Plenum Publishers.
11. Pinter A., Honnen W.J. Topography of murine leukemia virus envelope proteins: characterization of transmembrane components. J. Virol. 46:1983;1056-1060.
12. Fass D., Kim P.S. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr. Biol. 5:1995;1377-1383.
13. Carr C.M., Kim P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
14. Pinter A., Fleissner E. The presence of disulfide-linked gp70-p15(E) complexes in AKR murine leukemia virus. Virology. 83:1977;417-422.
15. Gliniak B.C., et al. Disulfide bonding controls the processing of retroviral envelope glycoproteins. J. Biol. Chem. 266:1991;22991-22997.
16. Ryser H.J., et al. Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J. Biol. Chem. 266:1991;18439-18442.
17. Freedman R.B. Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins. Cell. 57:1989;1069-1072.
18. Gallina A., et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277:2002;50579-50588.
19. Barbouche R., et al. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CxCR4 binding and is required for fusion. J. Biol. Chem. 278:2003;3131-3136.
20. Kemble G.W., et al. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76:1994;383-391.
21. Melikyan G.B., et al. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131:1995;679-691.
22. Weiss C.D., White J.M. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 67:1993;7060-7066.
23. Ragheb J.A., Anderson W.F. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J. Virol. 68:1994;3207-3219.
24. Taylor G.M., Sanders D.A. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol. Biol. Cell. 10:1999;2803-2815.
25. Melikyan G.B., et al. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol. Biol. Cell. 11:2000;3765-3775.
26. Langosch D., et al. Peptide mimics of the vesicular stomatitis virus G-protein transmembrane segment drive membrane fusion in vitro. J. Biol. Chem. 276:2001;32016-32021.
27. Cleverley D.Z., Lenard J. The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3425-3430.
28. Wilk T., et al. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology. 218:1996;269-274.
29. Kai K., et al. Mouse strain resistant to N-, B-, and NB-tropic murine leukemia viruses. J. Virol. 20:1976;436-440.
30. Odaka T., et al. Fv-4: gene controlling resistance to NB-tropic Friend murine leukemia virus. Distribution in wild mice, introduction into genetic background of BALB/c mice, and mapping of chromosomes. J. Natl. Cancer Inst. 67:1981;1123-1127.
31. Suzuki S. FV-4: a new gene affecting the splenomegaly induction by Friend leukemia virus. Jpn. J. Exp. Med. 45:1975;473-478.
32. Zhang F., et al. Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system. J. Virol. 74:2000;6193-6197.
33. Ikeda H., et al. Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance. J. Virol. 55:1985;768-777.
34. Masuda M., Yoshikura H. Construction and characterization of the recombinant Moloney murine leukemia viruses bearing the mouse Fv-4 env gene. J. Virol. 64:1990;1033-1043.
35. Albritton L.M., et al. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 57:1989;659-666.
36. Limjoco T.I., et al. Transgenic Fv-4 mice resistant to Friend virus. J. Virol. 67:1993;4163-4168.
37. Higo K., et al. Susceptibility of nude mice carrying the Fv-4 gene to Friend murine leukemia virus infection. J. Virol. 71:1997;750-754.
38. Ikeda H., Sugimura H. Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J. Virol. 63:1989;5405-5412.
39. Ikeda H., Odaka T. Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection. Virology. 128:1983;127-139.
40. Taylor G.M., et al. Fv-4: identification of the defect in env and the mechanism of resistance to ecotropic murine leukemia virus. J. Virol. 75:2001;11244-11248.
41. Rein A., Schultz A. Different recombinant murine leukemia viruses use different cell surface receptors. Virology. 136:1984;144-152.
42. Kim J.W., Cunningham J.M. N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. J. Biol. Chem. 268:1993;16316-16320.
43. Kitagawa M., et al. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts. Leukemia. 15:2001;1779-1784.
44. Best S., et al. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature. 382:1996;826-829.
45. Kozak C.A., Chakraborti A. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology. 225:1996;300-305.
46. Towers G., et al. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12295-12299.
47. Cowan S., et al. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11914-11919.
48. Besnier C., et al. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11920-11925.